DAVID SPIEGEL: Open Payments
NPI 1518934728 · NORFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$91,094 in 162 payments from 12 companies in 2025. Trend: 2023 $101,240 · 2024 $43,215 · 2025 $91,094
Speaker / faculty: $81,085Travel & lodging: $3,816Consulting: $3,297Food & beverage: $2,897
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 43 | $47,386 |
| Alkermes, Inc. | 23 | $25,235 |
| ABBVIE INC. | 38 | $10,008 |
| Vanda Pharmaceuticals Inc. | 11 | $6,489 |
| E.R. Squibb & Sons, L.L.C. | 14 | $1,362 |
| Lundbeck LLC | 17 | $258 |
| Eisai Inc. | 4 | $116 |
| Teva Pharmaceuticals USA, Inc. | 3 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $58 |
| Axsome Therapeutics, Inc. | 2 | $42 |
Products named: CAPLYTA, LYBALVI, VRAYLAR, FANAPT, COBENFY, REXULTI, Leqembi, ARISTADA.
Industry payments across VA — which companies pay providers there.
